Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nova Measuring Instruments Ltd. - Ordinary Shares | NMR | May 17, 2024 | 179.00 | -3.24 |
Nova Mentis Life Science Corp | HN3Q | May 17, 2024 | 0.01 | 0.00 |
Nova Minerals Limited | QM3 | May 17, 2024 | 0.14 | -4.10 |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NVQ | May 17, 2024 | 6.55 | -0.76 |
Novabay Pharmaceuticals | B9P | May 17, 2024 | 0.16 | +87.28 |
Novacyt | NYZ | May 17, 2024 | 0.70 | -2.37 |
Novagold Resources Inc. | NGR | May 17, 2024 | 2.98 | +4.63 |
Novanta Inc. - | 1GSN | May 17, 2024 | 151.00 | -1.95 |
Novartis AG | NOTA | May 17, 2024 | 92.60 | -1.07 |
Novavax, Inc. | NVV1 | May 17, 2024 | 12.16 | -9.02 |
Novem Group S.A. | NVM | May 17, 2024 | 5.74 | +5.51 |
NOVINA S.A. E ZY 1,16 | T36 | May 17, 2024 | 0.17 | -7.16 |
NOVIQTECH LTD. | 63Q0 | May 17, 2024 | 0.00 | 0.00 |
Novo Nordisk A/S | NOVA | May 17, 2024 | 121.50 | -0.82 |
Novo Resources Corp | 1NO | May 17, 2024 | 0.09 | +3.54 |
NovoCure Limited - Ordinary Shares | 038 | May 17, 2024 | 21.00 | +3.04 |
NOVONIX ADR | GC30 | May 17, 2024 | 2.06 | -1.90 |
Novonix Limited | GC3 | May 17, 2024 | 0.56 | +10.58 |
Novozymes AS | NZM | May 17, 2024 | 56.50 | +0.89 |
Novozymes B | NZM2 | May 17, 2024 | 58.00 | +1.15 |
Novra Technologies Inc. | 7CV | May 17, 2024 | 0.04 | +23.73 |
Novus Holdings Limited | N09 | May 17, 2024 | 0.20 | +1.01 |
NOW Inc. | 11N | May 17, 2024 | 12.80 | 0.00 |
NP3 Fastigheter | N33 | May 17, 2024 | 22.20 | -1.55 |
NPC Inc | 59N | May 17, 2024 | 5.25 | -0.94 |
NRC Group | 8NR | May 17, 2024 | 1.13 | 0.00 |
NRG Energy Inc. | NRA | May 17, 2024 | 75.50 | -4.11 |
NRJ Group | NR8 | May 17, 2024 | 7.68 | +0.26 |
NRW Holdings Limited | 3NR | May 17, 2024 | 1.63 | -0.61 |
Ns United Kaiun Kaisha, Ltd. | 8WN | May 17, 2024 | 28.80 | +0.70 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.